thank for inform to me. its very intresting On 8/25/10, jaleel uc <[email protected]> wrote: >> >> >> BOSTON, Aug. 23, 2010 — An unlikely effort is underway to lift the veil of >> nearly-total secrecy that has surrounded the process of developing new >> prescription drugs for the last century, scientists said today at the >> 240th >> National Meeting of the American Chemical Society (ACS). The upheaval in >> traditional practice would make key data available to college students, >> university professors, and others in an open, collective process. >> >> Called open-source drug discovery, the new approach involves an online >> community of computer users from around the world working together to >> discover and develop much-needed new drugs. It could lead to inexpensive >> drugs to treat a wide variety of diseases, including tuberculosis and >> malaria, that claim a huge toll in developing countries. >> >> Scientists from government, industry, and academia are presenting a dozen >> reports on this topic during a special symposium entitled "Open-source >> Drug >> Discover" at the ACS meeting. >> >> Open-source drug discovery is a movement as well as an evolving program. >> The Open Source Drug Discovery (OSDD) Consortium, for instance, is a >> worldwide scientific community of more than 3000 people from 74 countries >> that was launched in 2008 by India's Council of Scientific and Industrial >> Research (CSIR), the country's largest research and development >> organization. People can participate in the program by logging into a Web >> site: www.osdd.net >> >> "I believe this is the way to go about not only drug discovery, but it may >> be a way of doing science in the future," said OSDD Project Director Samir >> Brahmachari, Ph.D. "Everybody can contribute." >> >> Brahmachari, who is director general of CSIR and one of the pioneers of >> the >> open-source movement, notes that most drug discoveries are made in a >> closed-door environment in which pharmaceutical companies keep drug >> development information under wraps and limit participation of the >> academic >> world, such as colleges and universities. The OSDD program aims to address >> this issue by attempting to attract the youngest and brightest minds >> around >> the globe to be part of the drug discovery movement, he said. >> >> One of the aims of the project is to develop a new drug for tuberculosis, >> which kills almost two million people each year worldwide. OSDD recently >> announced a step toward this goal by providing a comprehensive map of the >> genome of Mycobacterium tuberculosis, the bacterium that causes the >> disease. >> >> >> "Open-source drug R&D is a broad concept that has many faces," said >> Michael >> Hurrey, Ph.D., program chair of the ACS Division of Business Development >> and >> Management, which is hosting the symposium. He is currently a chemist with >> Vertex Pharmaceuticals in Cambridge, Mass. "Our symposium will feature >> some >> of its proudest accomplishments in the hope that some in the audience will >> feel emboldened to join the movement and build upon that foundation >> >> >> Press Release >> >> >> >> The ACS Division of Business Development and Management (BMGT) is >> sponsoring a full day symposium on Open-Source Drug Discovery as part >> of the 240th National Meeting of the American Chemical Society. >> Speakers include pioneers of the open-source drug discovery movement >> who will discuss their first-hand experiences in creating the tools >> and platforms that enable the online collaboration of thousands of >> scientists working to economically discover and develop much needed >> drugs for the treatment of rare and neglected diseases. >> >> >> >> Organized by Richard Harper of Indiana University-Purdue University >> Indianapolis (IUPUI) and Bernard Munos of Eli Lilly, co-sponsored by >> the ACS Division of Medicinal Chemistry and financially sponsored by >> Eli Lilly and Company, the OSDD symposium provides an opportunity for >> attendees to learn about the present and future of open-source >> innovation and hear international practitioners from academia and >> industry describe their approaches to setting up and operating open- >> source drug R&D programs. >> >> >> >> Scheduled for Monday, August 23, 2010 in Room 254A/B of the Boston >> Convention & Exhibition Center, the morning session begins at 8:30 >> with opening remarks by Harper and Munos followed by presentations >> from Dr. Samir Brahmachari of India’s Council for Scientific and >> Industrial Research (CSIR)i, Dr. Christopher Austin from the NIH >> Chemical Genomics Center and Dr. Solomon Nwaka of the World Health >> Organization. After a short intermission, the session will continue >> with talks by Dr. F. Javier Gamo of GlaxoSmithKline and Dr. Alpheus >> Bingham from InnoCentive, and end with a panel discussion. >> >> >> >> Harper and Munos will also open the afternoon session beginning at >> 1:30. Speakers will include Munos, Dr. Zakir Thomas >> begin_of_the_skype_highlighting end_of_the_skype_highlighting from >> the Open Source Drug Discovery program with CSIR, Dr. Marta Piñeiro- >> Núñez of Eli Lilly and Company, Dr. William Scott from IUPUI and Dr. >> Sean Ekins of Collaborative Drug Discovery. A final panel discussion >> will end the symposium. >> >> >> >> Some of the topics to be covered by these leading experts in open- >> source drug discovery technology include activities at the NIH to >> develop innovative and collaborative later stage drug development >> programs, efforts by the WHO to foster novel approaches for research >> in neglected diseases, the sharing by GSK of data on over 13,500 >> potential anti-malarial compounds, India’s OSDD program activities >> involving 3000 people in 74 countries, Lilly’s phenotypic drug >> discovery initiative (PD2), distributed drug discovery and >> collaborative drug discovery and the various ways in which OSDD can >> make it possible for global partnerships across academia, government >> and industry to reduce the cost of drug development and make novel >> treatments available for the very poor. >> >> >> >> Directly following the symposium, there will be a reception and book >> signing with Roger F. Jones, author of The Future of the Chemical >> Industry, an ACS Symposium Series publication and his fourth and >> latest book on industrial, technical, economic and managerial issues >> in the chemical industry. >> >> >> >> “We are very excited to be sponsors of this unique event at the >> National ACS meeting,” states Dr Alan D. Palkowitz, Ph.D., Vice >> President, Discovery Chemistry Research & Technologies, Eli Lilly and >> Company. “The current pharmaceutical R&D model is being redesigned in >> part by this new approach, which is also channeling drug research into >> neglected and rare diseases. The speaker line-up represents people in >> organizations involved at the forefront of this movement. This >> symposium provides a forum for discussion of these early initiatives >> and we hope the audience will be inspired to help build on this >> foundation.” >> >> >> >> -- >> http://www.cbclickbank.com/bioinformatics/company.htm >> List of the biotech company and address. >> >> ------------------------------------------------------------------------------------------ >> Biofriend Forum >> http://www.biofriend.info/ >> ============================================= >> Meet Biofriend India Team Manager at Linkedin >> http://in.linkedin.com/in/satishchauk >> > > > > -- > Dr U.C.A.Jaleel. > Asst Professor in cheminformatics > Cheminformatics Division( UGC) > Malabar Christian College > Calicut University > > -- > http://www.cbclickbank.com/bioinformatics/company.htm > List of the biotech company and address. > ------------------------------------------------------------------------------------------ > Biofriend Forum > http://www.biofriend.info/ > ============================================= > Meet Biofriend India Team Manager at Linkedin > http://in.linkedin.com/in/satishchauk >
-- http://www.cbclickbank.com/bioinformatics/company.htm List of the biotech company and address. ------------------------------------------------------------------------------------------ Biofriend Forum http://www.biofriend.info/ ============================================= Meet Biofriend India Team Manager at Linkedin http://in.linkedin.com/in/satishchauk
